Boothbay Fund Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1987 |
|
|
2023
Q2 | – | Sell |
-16,154
| Closed | -$1.47M | – | 2229 |
|
|
2023
Q1 | $1.47M | Buy |
+16,154
| New | +$1.47M | 0.03% | 681 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2276 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2425 |
|
|
2022
Q2 | – | Sell |
-8,564
| Closed | -$281K | – | 2444 |
|
|
2022
Q1 | $281K | Buy |
+8,564
| New | +$281K | 0.01% | 1298 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2097 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2046 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1997 |
|
|
2021
Q1 | – | Sell |
-2,680
| Closed | -$331K | – | 1648 |
|
|
2020
Q4 | $331K | Buy |
+2,680
| New | +$331K | 0.01% | 768 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1182 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1035 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1039 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 960 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 865 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 851 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 835 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 871 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 870 |
|